Your Bio-Innovation Partner
We help lower the cost of validating new bio-based technologies with a capital light approach. Functioning as a contract research organization, our $17 million state-of-the art facility is available to the bio-based products industry on an op-ex basis. We consider ourselves a proving ground and incubator for bio-innovation.
We are equally relevant as a bio-innovation partner for emerging technologies and nascent processes from emerging seed-funded or venture backed startups, as well as large companies seeking to diversify their product portfolio.